Rockefeller Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $666K | Buy |
|
|||||
|
2023
Q1 | $588K | Hold |
|
|||||
|
2022
Q4 | $245K | Buy |
|
|||||
|
2022
Q3 | $138K | Sell |
|
|||||
|
2022
Q2 | $191K | Buy |
|
|||||
|
2022
Q1 | $200K | Buy |
|
|||||
|
2021
Q4 | $32K | Sell |
|
|||||
|
2021
Q3 | $345K | Sell |
|
|||||
|
2021
Q2 | $623K | Buy |
|
|||||
|
2021
Q1 | $169K | Hold |
|
|||||
|
2020
Q4 | $210K | Sell |
|
|||||
|
2020
Q3 | $169K | Buy |
|
|||||
|
2020
Q2 | $4K | Sell |
|
|||||
|
2020
Q1 | $6K | Sell |
|
|||||
|
2019
Q4 | $10K | Hold |
|
|||||
|
2019
Q3 | $4K | Buy |
|